Strumento inattivo

Azioni Algeta ASA Other OTC

Azioni

Prezzo di chiusura Other OTC Altri mercati azionari
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Actavis : M&A frenzy in healthcare sector	06/05/14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24/03/14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24/02/14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20,03%	126 Mrd
REGENERON PHARMACEUTICALS, INC.	+23,61%	118 Mrd
ARGENX SE	+23,26%	27,87 Mrd
BIONTECH SE	-18,07%	20,95 Mrd
GENMAB A/S	-15,13%	16,92 Mrd
BEIGENE, LTD.	-14,81%	16,18 Mrd
NEUROCRINE BIOSCIENCES, INC.	+9,78%	14,84 Mrd
WUXI APPTEC CO., LTD.	-46,10%	14,79 Mrd
SAREPTA THERAPEUTICS, INC.	+52,34%	14,08 Mrd